Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.
Naif Khalaf Al HarbiFahad AljamaanHaya A AljamiMohammed W AlenaziHind AlbalawiAbdulrahman AlmasoudFatima J AlharthiEsam Ibraheem AzharTlili BarhoumiMohammad BosaeedSarah C GilbertAnwar M HashemPublished in: Vaccines (2022)
MVA-MERS vaccine, administered in a homologous prime-boost regimen, induced high levels of neutralising anti-MERS-CoV antibodies in mice and camels. This could be considered for further development and evaluation as a dromedary vaccine to reduce MERS-CoV transmission to humans.